Showing results (1081-1090 of 16,216) with videos related to
Sort By:
Pageof 1,622
Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
Chiral resolution of the enantiomers of 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide using high-performance liquid chromatography on cellulose-based chiral stationary phasesG Cannazza, D Braghiroli, M Baraldi, et al.Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
In vitro and ex vivo anti- and prooxidant components of Cichorium intybusG Gazzani, M Daglia, A Papetti, et al.Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
Analysis and stability study of retinoids in pharmaceuticals by LC with fluorescence detectionR Gatti, M G Gioia, V CavriniJournal of Pharmaceutical and Biomedical Analysis|August 10, 2000
Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamineB Starczewska, K MielechJournal of Pharmaceutical and Biomedical Analysis|August 10, 2000
Indirect determination of captopril by AASM A El Reis, F M Abou Attia, I M KenawyJournal of Pharmaceutical and Biomedical Analysis|August 10, 2000
Assay of ephedrine hydrochloride and theophylline in pharmaceutical formulations by differential-derivative spectroscopyN ErkJournal of Pharmaceutical and Biomedical Analysis|August 10, 2000
Study on electrooxidation of cefadroxil monohydrate and its determination by differential pulse voltammetryS A Ozkan, N Erk, B Uslu, et al.Journal of Pharmaceutical and Biomedical Analysis|August 10, 2000
Determination of bile acids in pharmaceutical formulations using micellar electrokinetic chromatographyV G Rodríguez, S E Lucangioli, G C Fernández Otero, et al.Journal of Pharmaceutical and Biomedical Analysis|August 10, 2000
Characterization of clinafloxacin photodegradation products by LC-MS/MS and NMRM J Lovdahl, S R PriebeJournal of Pharmaceutical and Biomedical Analysis|August 10, 2000
In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of phase I clinical studiesA F Aubry, D Sebastian, T Hobson, et al.Pageof 1,622